Clinical Trials
20
Active:0
Completed:10
Trial Phases
4 Phases
Phase 1:1
Phase 3:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Not Applicable
11 (78.6%)Phase 1
1 (7.1%)Phase 3
1 (7.1%)Phase 4
1 (7.1%)Liquid Biopsy Assay of EBUS-TBNA Supernatant Fluid for Diagnosing Lung Cancer
Recruiting
- Conditions
- Non Small Cell Lung CancerLung Cancer - Non Small CellNon Small Cell Lung Cancer (NSCLC)Lung Cancer (NSCLC)Pulmonary Nodule
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Barzilai Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT06889467
- Locations
- 🇮🇱
Barzilai University Medical Center, Ashkelon, Israel
Telomeres Length in Israeli Fibrotic ILD Patients
Not yet recruiting
- Conditions
- Pulmonary Fibrosis
- First Posted Date
- 2025-03-20
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Barzilai Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT06885515
Evaluating the Effectiveness of Using a Home Laser Device to Treat Patients With Knee Osteoarthritis
Not Applicable
Recruiting
- Conditions
- Osteoarthritis Of Knee
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Barzilai Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT06773676
- Locations
- 🇮🇱
Barzilai University Medical Center, Ashkelon, Southern Region, Israel
Intrauterine Hyaluronic Acid Gel for Prevention of Intrauterine Adhesions
Not Applicable
- Conditions
- Prevenetion of Intrauterine Adhesions by Hyaluronic Acid Gel
- Interventions
- Drug: Intrauterine injection of hyaluronic acid
- First Posted Date
- 2021-07-23
- Last Posted Date
- 2021-07-23
- Lead Sponsor
- Barzilai Medical Center
- Target Recruit Count
- 160
- Registration Number
- NCT04975373
- Locations
- 🇮🇱
Barzilai University Medical Center, Ashkelon, Israel
Xanthine Oxidase and Uric Acid Origin in Preeclamptic Women
- Conditions
- HyperuricemiaPre-Eclampsia
- First Posted Date
- 2020-07-09
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Barzilai Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT04463940
- Locations
- 🇮🇱
Barzilai Medical Center, Ashkelon, Israel
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found